Neochem Bio Solutions IPO
Neochem Bio Solutions IPO Details
-
Open Date
02 Dec 2025
-
Close Date
04 Dec 2025
-
Listing Date
09 Dec 2025
- IPO Price Range
₹ 93 to ₹98
- IPO Size
₹ 44.97 Cr
- Listing Exchange
NSE SME
Neochem Bio Solutions IPO Timeline
Neochem Bio Solutions IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 2-Dec-2025 | 1.00 | 1.10 | 0.50 | 0.77 |
| 3-Dec-2025 | 1.23 | 2.00 | 1.01 | 1.29 |
| 4-Dec-2025 | 21.97 | 21.15 | 9.42 | 15.52 |
Last Updated: 04 December 2025 6:15 PM by 5paisa
Neochem Bio Solutions Ltd. manufactures specialty performance chemicals used across industries including textiles and garment washing, home and personal care, institutional and industrial cleaning, water treatment, paints and coatings, paper and pulp, construction, rubber, and dyes and pigments. The company provides a wide range of textile and garment washing auxiliaries for pre-treatment, dyeing, finishing, printing, and coating. Its manufacturing facility in Moraiya, Ahmedabad, spans 6,763 sq. m with a 22,000 MTPA capacity.
Established in: 2006
Managing Director: Swapnil Rameshbhai Makati
Neochem Bio Solutions Objectives
1. The company will fund long-term working capital needs (₹23.90 Cr).
2. It plans to repay or prepay outstanding borrowings (₹10.00 Cr).
3. Funds will also support general corporate purposes.
Neochem Bio IPO Size
| Types | Size |
|---|---|
| Total IPO Size | ₹44.97 Cr |
| Offer For Sale | - |
| Fresh Issue | ₹44.97 Cr |
Neochem Bio IPO Lot Size
| Application | Lots | Shares | Amount (₹) |
| Retail (Min) | 2 | 2,400 | 2,23,200 |
| Retail (Max) | 2 | 2,400 | 2,35,200 |
| S - HNI (Min) | 3 | 3,600 | 3,34,800 |
| S - HNI (Max) | 8 | 9,600 | 9,40,800 |
| B - HNI (Max) | 9 | 10,800 | 10,04,400 |
Neochem Bio IPO Reservation
| Investors Category | Subscription (times) | Shares Offered* | Shares bid for | Total Amount (Cr.)* |
|---|---|---|---|---|
| QIB (Ex Anchor) | 21.97 | 8,71,200 | 1,91,42,400 | 187.596 |
| Non-Institutional Buyers | 21.15 | 6,55,200 | 1,38,55,200 | 135.781 |
| bNII (bids above ₹10L) | 25.78 | 4,36,800 | 1,12,60,800 | 110.356 |
| sNII (bids below ₹10L) | 11.88 | 2,18,400 | 25,94,400 | 25.425 |
| Individual Investors (IND category bidding for 2 Lots) | 9.42 | 15,26,400 | 1,43,76,000 | 140.885 |
| Total** | 15.52 | 30,52,800 | 4,73,73,600 | 464.261 |
*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Revenue | 48.79 | 62.01 | 86.15 |
| EBITDA | 4.23 | 5.991 | 3.11 |
| Profit After Tax (PAT) | 1.07 | 1.80 | 7.75 |
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Total Assets | 50.60 | 64.06 | 78.89 |
| Share Capital | 5.43 | 6.68 | 6.68 |
| Total Liabilities | 50.60 | 64.06 | 78.89 |
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Net Cash Generated From / (used in) Operating Activities | -0.74 | 1.96 | 2.59 |
| Net Cash Generated From / (used in) Investing Activities | -3.35 | -7.86 | -1.69 |
| Net Cash Generated From / (used in) Financing Activities | 3.76 | 6.20 | -1.20 |
| Net Increase / (Decrease) In Cash And Cash Equivalents | -0.34 | 0.30 | -0.30 |
Strengths
1. Strong presence in diverse chemical industry segments.
2. Wide range of textile processing auxiliaries offered.
3. Modern facility with 22,000 MTPA capacity.
4. Experienced team ensuring consistent product quality standards.
Weaknesses
1. Reliance on industrial demand cycles remains significant.
2. Limited global brand visibility outside core markets.
3. High working capital needs affect flexibility.
4. Product portfolio sensitive to raw material prices.
Opportunities
1. Growing demand for specialised performance chemicals globally.
2. Expansion potential in home and personal care.
3. Adoption of sustainable chemical solutions increasing rapidly.
4. Opportunity to scale production through capacity enhancements.
Threats
1. Intense competition from established chemical manufacturers.
2. Environmental regulations could raise compliance costs.
3. Volatile raw material prices impacting margins.
4. Slower industrial growth may reduce product demand.
1. Strong presence across multiple high-demand industries.
2. Expanding product range drives future scalability.
3. Modern facility supports efficient large-scale production.
4. IPO proceeds strengthen liquidity and financial stability.
Neochem Bio operates across diverse industrial segments, supplying essential specialty performance chemicals to textiles, home and personal care, water treatment, coatings and more. With an advanced manufacturing facility and expanding product portfolio, the company is positioned to benefit from rising demand for high-performance and sustainable chemical solutions. Its scalable capacity and presence in multiple end-use industries support steady long-term growth potential.
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
By proceeding, you agree to all T&C*
FAQs
Neochem Bio IPO opens from December 2, 2025 to December 4, 2025.
The size of Neochem Bio IPO is ₹45.97 Cr.
The price band of Neochem Bio IPO is fixed at ₹93 to ₹98 per share
To apply for Neochem Bio IPO, follow the steps given below:
● Login to your 5paisa demat account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Neochem BioIPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
You will receive a mandate notification to block funds in your UPI app.
The minimum lot size of Neochem Bio IPO is of 2,400 shares and the investment required is ₹2,23,200.
The share allotment date of Neochem Bio IPO is December 5, 2025
The Neochem Bio IPO will likely be listed on December 9, 2025.
The book running lead managers for Neochem Bio IPO is Vivro Financial Services Pvt.Ltd.
Neochem Bio IPO plans to utilise the raised capital from the IPO for:
1. The company will fund long-term working capital needs (₹23.90 Cr).
2. It plans to repay or prepay outstanding borrowings (₹10.00 Cr).
3. Funds will also support general corporate purposes.